Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Parenteral nutrient supply, also known as parenteral nutrition (PN), is a method of providing nutrition intravenously, bypassing the gastrointestinal tract. It involves the administration of a complex mixture of carbohydrates, amino acids, lipids, electrolytes, vitamins, and trace elements tailored to meet individual patient needs. PN is indicated when oral or enteral feeding is not possible, insufficient, or contraindicated. It is crucial for managing patients with intestinal failure, severe malabsorption, or other conditions that prevent adequate nutrient absorption through the digestive system. Careful monitoring of metabolic parameters and potential complications is essential for safe and effective PN therapy.
Intravenous delivery of essential nutrients directly into the bloodstream, bypassing the gastrointestinal tract, to provide nutritional support when oral or enteral feeding is not feasible.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Parenteral Nutrient Supply (None).